{"name":"Cellerant Therapeutics","permalink":"cellerant-therapeutics","crunchbase_url":"http://www.crunchbase.com/company/cellerant-therapeutics","homepage_url":"http://www.cellerant.com/","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"info@cellerant.com","phone_number":"650-232-2122","description":"biotechnology company","created_at":"Sat Sep 12 15:13:24 UTC 2009","updated_at":"Fri Jun 15 01:35:29 UTC 2012","overview":"<p>Cellerant Therapeutics is a biotechnology company with a portfolio of products based on the regulation of the hematopoietic (blood-forming) system. The company focuses on curative therapies for seriously ill patients.</p>\n\n<p>Cellerant is developing a novel, cell-based medicine (Myeloid Progenitors / CLT-008) as a treatment for chemotherapy- and radiation-induced neutropenia as well as for Acute Radiation Syndrome. And we are applying our expertise in hematopoietic ontogeny to identify novel drug targets and therapeutic antibodies aimed at cancer stem cells.</p>","image":{"available_sizes":[[[150,41],"assets/images/resized/0005/9578/59578v1-max-150x150.jpg"],[[172,48],"assets/images/resized/0005/9578/59578v1-max-250x250.jpg"],[[172,48],"assets/images/resized/0005/9578/59578v1-max-450x450.jpg"]],"attribution":null},"products":[],"relationships":[{"is_past":false,"title":"President & CEO","person":{"first_name":"Ram","last_name":"Mandalam","permalink":"ram-mandalam","image":null}},{"is_past":false,"title":"Chairman","person":{"first_name":"Lowell","last_name":"Sears","permalink":"lowell-sears","image":null}}],"competitions":[],"providerships":[],"total_money_raised":"$37.1M","funding_rounds":[{"round_code":"b","source_url":"http://deals.venturebeat.com/2007/04/26/cellerant-therapeutics-raises-44m-for-stem-cell-therapeutics/","source_description":"Cellerant Therapeutics raises $4.4M for stem-cell therapeutics","raised_amount":4400000,"raised_currency_code":"USD","funded_year":2007,"funded_month":4,"funded_day":26,"investments":[]},{"round_code":"b","source_url":"http://cellerant.com/pdf/press_050511.pdf","source_description":"CELLERANT THERAPEUTICS RAISES $16 MILLION TO ADVANCE STEM CELL-BASED THERAPIES FOR LIFE-THREATENING DISEASES","raised_amount":16000000,"raised_currency_code":"USD","funded_year":2005,"funded_month":5,"funded_day":11,"investments":[{"company":null,"financial_org":{"name":"Novel Bioventures","permalink":"novel-bioventures","image":null},"person":null},{"company":null,"financial_org":{"name":"CX Venture Group","permalink":"cx-venture-group","image":{"available_sizes":[[[150,58],"assets/images/resized/0010/1197/101197v1-max-150x150.png"],[[250,97],"assets/images/resized/0010/1197/101197v1-max-250x250.png"],[[351,137],"assets/images/resized/0010/1197/101197v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Allen & Company","permalink":"allen-and-company","image":{"available_sizes":[[[150,11],"assets/images/resized/0016/9557/169557v3-max-150x150.png"],[[250,18],"assets/images/resized/0016/9557/169557v3-max-250x250.png"],[[450,33],"assets/images/resized/0016/9557/169557v3-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"MPM Capital","permalink":"mpm-capital","image":{"available_sizes":[[[150,142],"assets/images/resized/0004/5561/45561v1-max-150x150.png"],[[180,171],"assets/images/resized/0004/5561/45561v1-max-250x250.png"],[[180,171],"assets/images/resized/0004/5561/45561v1-max-450x450.png"]],"attribution":null}},"person":null}]},{"round_code":"grant","source_url":"https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=32&aid=DJFVW00020110916e79g00001&r=Rss&s=DJFVW","source_description":"Cellerant Thera Awarded Additional $16.7M For Radiation Treatment ","raised_amount":16700000,"raised_currency_code":"USD","funded_year":2011,"funded_month":9,"funded_day":15,"investments":[{"company":null,"financial_org":{"name":"BARDA","permalink":"barda","image":null},"person":null}]}],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"HQ","address1":"1561 Industrial Road","address2":"","zip_code":"94070","city":"San Carlos","state_code":"CA","country_code":"USA","latitude":37.4993106,"longitude":-122.2427204}],"milestones":[{"description":"Cellerant lands $153M BARDA contract for ARS program","stoned_year":2010,"stoned_month":9,"stoned_day":1,"source_url":"http://www.fiercebiotech.com/story/cellerant-nails-153m-barda-contract-ars-program/2010-09-01?utm_medium=rss&utm_source=rss","source_text":"","source_description":"Cellerant lands $153M BARDA contract for ARS program","stoneable_type":"Company","stoned_value":null,"stoned_value_type":null,"stoned_acquirer":null,"stoneable":{"name":"Cellerant Therapeutics","permalink":"cellerant-therapeutics"}}],"ipo":null,"video_embeds":[],"screenshots":[],"external_links":[]}